Dr. John E. Kerrigan is a Computational Biologist for UMDNJ  Academic Computing Services/ IS& T at the Robert Wood Johnson Medical School. He received his doctoral degree in organic chemistry under the direction of an enzymologist, James C. Powers, and a synthetic chemist, Patrick G. McDougal, at the Georgia Institute of Technology in Atlanta, GA.  While at Georgia Tech, Dr. Kerrigan became active in molecular modeling and structural biochemistry in his studies of mechanism-based inhibitors of serine proteases.  After postdoctoral study at Georgia Tech and The School of Medicine at UNC Chapel Hill, he accepted a faculty appointment at the University of South Alabama where he was active in undergraduate instruction and research.

After being relocated to New Jersey, he was a faculty member in the School of Pharmacy at Rutgers University before moving over to Academic Computing Services at UMDNJ.  Dr. Kerrigan is presently a member of the Cancer Institute of New Jersey and is in charge of research support services within Academic Computing Services at UMDNJ.  He is an instructor in the Structural Bioinformatics I and II courses within the Informatics Institute.

Dr. Kerrigan's research interests cover a wide range of molecular modeling-oriented projects from biophysical to drug design.  Recent collaborations include: Design of Topoisomerase I Inhibitors (RWJMS and Rutgers); Biophysical Studies of Amyloid Beta Proteins and Alpha-Crystalline (NJMS); DNA Polymer Crosslinkers (Rutgers Biomedical Engineering); DNA Structure in the Gas Phase (Rutgers Chemistry); Design of Novel Antitumor Agents (Rutgers Pharmacy); Monoclonal Antibodies (RWJMS) and Studies of Aminoglycoside Antibiotics (RWJMS).